Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Colorcon
Merck
McKinsey
Medtronic

Last Updated: January 26, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Cebranopadol


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Cebranopadol?

Cebranopadol is an investigational drug.

There have been 7 clinical trials for Cebranopadol. The most recent clinical trial was a Phase 3 trial, which was initiated on December 18th 2013.

The most common disease conditions in clinical trials are Chronic Pain, Substance-Related Disorders, and Peripheral Nervous System Diseases. The leading clinical trial sponsors are Grünenthal GmbH, Tris Pharma, Inc., and Forest Laboratories.

There are fifty-eight US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Cebranopadol
TitleSponsorPhase
CORAL XT - Open-label Extension Trial of the CORAL TrialGrünenthal GmbHPhase 3
CORAL XT - Open-label Extension Trial of the CORAL TrialTris Pharma, Inc.Phase 3
CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to CancerGrünenthal GmbHPhase 3

See all Cebranopadol clinical trials

Clinical Trial Summary for Cebranopadol

Top disease conditions for Cebranopadol
Top clinical trial sponsors for Cebranopadol

See all Cebranopadol clinical trials

US Patents for Cebranopadol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cebranopadol ⤷  Sign up for a Free Trial Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function GRUNENTHAL GMBH (Aachen, DE) ⤷  Sign up for a Free Trial
Cebranopadol ⤷  Sign up for a Free Trial Abuse-proofed dosage form GRUNENTHAL GMBH (Aachen, DE) ⤷  Sign up for a Free Trial
Cebranopadol ⤷  Sign up for a Free Trial Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc GRUENENTHAL GMBH (Aachen, DE) ⤷  Sign up for a Free Trial
Cebranopadol ⤷  Sign up for a Free Trial Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexa- ne-1,1'-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative Gruenenthal GmbH (Aachen, DE) ⤷  Sign up for a Free Trial
Cebranopadol ⤷  Sign up for a Free Trial Hot-melt extruded pharmaceutical dosage form GRUENENTHAL GMBH (Aachen, DE) ⤷  Sign up for a Free Trial
Cebranopadol ⤷  Sign up for a Free Trial Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Sign up for a Free Trial
Cebranopadol ⤷  Sign up for a Free Trial Tamper-resistant dosage form containing one or more particles GRUNENTHAL GMBH (Aachen, DE) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Cebranopadol

Drugname Country Document Number Estimated Expiration Related US Patent
Cebranopadol Australia AU2016208779 2035-01-23 ⤷  Sign up for a Free Trial
Cebranopadol Canada CA2974578 2035-01-23 ⤷  Sign up for a Free Trial
Cebranopadol China CN107427493 2035-01-23 ⤷  Sign up for a Free Trial
Cebranopadol Denmark DK3247352 2035-01-23 ⤷  Sign up for a Free Trial
Cebranopadol Eurasian Patent Organization EA201791662 2035-01-23 ⤷  Sign up for a Free Trial
Cebranopadol European Patent Office EP3247352 2035-01-23 ⤷  Sign up for a Free Trial
Cebranopadol European Patent Office EP3735970 2035-01-23 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Colorcon
Merck
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.